Anthea Pharma Private Limited

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Anthea Pharma Private Limited is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Anthea Pharma Private Limited

Anthea Pharma Private Limited is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by BUMETANIDE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: usage bumetanide, injection indicated, treatment edema, congestive heart, failure hepatic, renal disease, nephrotic syndrome, almost equal. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
BUMETANIDE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAMUSCULAR 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Anthea Pharma Private Limited

Brand nameGenericTypeRoute
Bumetanide BUMETANIDE HUMAN PRESCRIPTION DRUG INTRAMUSCULAR

Frequently asked questions

How many FDA drug products does Anthea Pharma Private Limited make?
1 FDA drug label records name Anthea Pharma Private Limited as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Anthea Pharma Private Limited produce?
The most frequent active ingredients in this portfolio are BUMETANIDE.

Are Anthea Pharma Private Limited products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.